Passionate partnerships are a central way of doing business at Pharmacosmos. They are also central to our aspiration to change the way iron deficiency is prevented and treated in humans and animals. Through partnerships we form ideas, develop compounds, run non-clinical and clinical trials, secure distribution chains and increase our global sales and marketing presence.
Partnering to us means co-creation, taking strides together and making sure that success is to our mutual benefit. We focus on being dependable, transparent and trustworthy – and taking the time and allocating the resources needed to foster a valuable and respecting collaboration.
We have a great track record in establishing and developing long-term partnerships – and wish to continue doing so.
Please click on the relevant area below to learn more about the opportunities to partner with us.
We are committed to change the way iron deficiency anaemia is prevented and treated in humans and animals – all over the world. To do that, we work focused to expand our global presence and have done so with success since 1965.
We have our own organisations in Denmark, the US, China, UK, Germany, Ireland, Sweden and Norway and we work through dedicated partnerships with diligent people and capable organisations elsewhere around the globe.
We furthermore partner with the international medical community in search for even better treatments for humans and veterinary use. Over the years and continuing today, we have conducted and are conducting clinical studies in a number of countries, including the US. We drive our clinical studies out of Denmark and execute them with assistance from local contract research organisations.
We are more than 500 employees in Denmark and our subsidiaries in the US, China, UK, Ireland, Germany, Sweden and Norway.
